Management of Traditional Cardiovascular Risk Factors in CKD: What Are the Data?

American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
L Parker Gregg, S Susan Hedayati

Abstract

Patients with non-dialysis-dependent chronic kidney disease (NDD-CKD) are 10 times more likely to die of cardiovascular (CV) diseases than the general population, and dialysis-dependent patients are at even higher risk. Although traditional CV risk factors are highly prevalent in individuals with CKD, these patients were often excluded from studies targeting modification of these risks. Although treatment of hypertension is beneficial in CKD, the best target blood pressure has not been established. Trial data showed that renin-angiotensin-aldosterone blockade may prevent CV events in patients with CKD. The risks of aspirin may equal the benefits in NDD-CKD samples, and there are no trials testing aspirin in dialysis-dependent patients. Lipid-lowering therapy improves CV outcomes in NDD-CKD, but not in dialysis-dependent patients. Strict glycemic control prevents CV events in nonalbuminuric individuals, but showed no benefit in those with baseline albuminuria with albumin excretion > 300mg/g, and there are no data in dialysis-dependent patients. Data for lifestyle modifications, such as weight loss, physical activity, and smoking cessation, are mostly observational and extrapolated from non-CKD samples. This comprehensive review...Continue Reading

References

Aug 15, 1998·The New England Journal of Medicine·UNKNOWN Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy (PURSUIT) Trial Investigato
Apr 14, 1999·Kidney International·E FleischmannA K Salahudeen
Jul 8, 2000·Kidney International·A K CheungA S Levey
Sep 22, 2001·The New England Journal of Medicine·B M BrennerUNKNOWN RENAAL Study Investigators
Feb 19, 2002·Kidney International·Francesca MallamaciUNKNOWN CREED Investigators
May 2, 2002·Kidney International. Supplement·Christoph WannerThomas Metzger
Jul 31, 2002·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Frank FungCatherine Stehman-Breen
Nov 21, 2002·JAMA : the Journal of the American Medical Association·Jackson T WrightUNKNOWN African American Study of Kidney Disease and Hypertension Study Group
Dec 20, 2002·JAMA : the Journal of the American Medical Association·UNKNOWN ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatm
Jan 29, 2003·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Ann M O'HareKirsten L Johansen
May 14, 2003·Journal of the American College of Cardiology·Gennaro CiceRaffaele Calabrò
Jul 28, 2004·The American Journal of Clinical Nutrition·Kirsten L JohansenGlenn M Chertow
Oct 20, 2004·Circulation·Folkert W AsselbergsUNKNOWN Prevention of Renal and Vascular Endstage Disease Intervention Trial (PREVEND IT) Investigators
Mar 9, 2005·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Colin BaigentDavid C Wheeler
Mar 10, 2005·The American Journal of Clinical Nutrition·Kamyar Kalantar-ZadehTamara B Horwich
Mar 23, 2005·Kidney International·Krista F HuybrechtsGérard M London
Apr 5, 2005·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Austin G StackBhamidipati V R Murthy
Apr 14, 2005·JAMA : the Journal of the American Medical Association·Michael G ShlipakBruce Psaty
Jul 22, 2005·The New England Journal of Medicine·Christoph WannerUNKNOWN German Diabetes and Dialysis Study Investigators
Jun 13, 2006·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Akihiko TakahashiYasuaki Dohi
Sep 7, 2007·Journal of the American Society of Nephrology : JASN·Vlado PerkovicJohn Chalmers
Sep 29, 2007·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Jean EthierEric W Young
Oct 19, 2007·Clinical Journal of the American Society of Nephrology : CJASN·Pooneh AlborziRajiv Agarwal
May 31, 2008·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Martin TepelWalter Zidek
Jun 10, 2008·The New England Journal of Medicine·Anushka PatelFlorence Travert
Jun 10, 2008·The New England Journal of Medicine·UNKNOWN Action to Control Cardiovascular Risk in Diabetes Study GroupWilliam T Friedewald
Jul 26, 2008·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Hiromichi SuzukiRyuichiro Araki
Apr 1, 2009·The New England Journal of Medicine·Bengt C FellströmUNKNOWN AURORA Study Group
Apr 25, 2009·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Takao SarutaUNKNOWN CASE-J Study Group

❮ Previous
Next ❯

Citations

Apr 9, 2020·Toxins·Thomas EbertPeter Stenvinkel
Sep 29, 2020·Frontiers in Endocrinology·Sarah BuchananPaul G Shiels
Feb 20, 2019·Diseases·Nima H JazaniNosratola D Vaziri
Jun 24, 2019·Current Atherosclerosis Reports·Sehrish AliSankar D Navaneethan
Jan 28, 2021·Circulation·Salim S ViraniUNKNOWN American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee
Dec 15, 2020·The British Journal of Nutrition·Zhuxian ZhangXianhui Qin
Feb 3, 2021·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·Ryan KabirSubhash Banerjee
May 31, 2021·Clinical Journal of the American Society of Nephrology : CJASN·Zhuxian ZhangXianhui Qin
Sep 7, 2021·International Urology and Nephrology·Xu YouHe Qun Zou

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.